[go: up one dir, main page]

AU2001261338A1 - Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder - Google Patents

Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder

Info

Publication number
AU2001261338A1
AU2001261338A1 AU2001261338A AU6133801A AU2001261338A1 AU 2001261338 A1 AU2001261338 A1 AU 2001261338A1 AU 2001261338 A AU2001261338 A AU 2001261338A AU 6133801 A AU6133801 A AU 6133801A AU 2001261338 A1 AU2001261338 A1 AU 2001261338A1
Authority
AU
Australia
Prior art keywords
hydroxylase
polymorphisms
association
bipolar disorder
dopamine beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261338A
Inventor
J. Raymond Depaulo Jr.
Eric S. Lander
Melvin G. Mcinnis
James Potash
Pamela Sklar
Virginia Willour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Johns Hopkins University
Whitehead Institute for Biomedical Research
Original Assignee
General Hospital Corp
Johns Hopkins University
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Johns Hopkins University, Whitehead Institute for Biomedical Research filed Critical General Hospital Corp
Publication of AU2001261338A1 publication Critical patent/AU2001261338A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001261338A 2000-05-10 2001-05-10 Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder Abandoned AU2001261338A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20291000P 2000-05-10 2000-05-10
US60/202,910 2000-05-10
PCT/US2001/015026 WO2001086000A2 (en) 2000-05-10 2001-05-10 Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder

Publications (1)

Publication Number Publication Date
AU2001261338A1 true AU2001261338A1 (en) 2001-11-20

Family

ID=22751714

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261338A Abandoned AU2001261338A1 (en) 2000-05-10 2001-05-10 Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder

Country Status (4)

Country Link
US (1) US6913885B2 (en)
EP (1) EP1356089A2 (en)
AU (1) AU2001261338A1 (en)
WO (1) WO2001086000A2 (en)

Also Published As

Publication number Publication date
WO2001086000A3 (en) 2003-04-24
WO2001086000A2 (en) 2001-11-15
US20030027172A1 (en) 2003-02-06
EP1356089A2 (en) 2003-10-29
US6913885B2 (en) 2005-07-05

Similar Documents

Publication Publication Date Title
AU2001240473A1 (en) Variants with altered properties
AU2710301A (en) Novel remedies with the use of beta3 agonist
AU2002210380A1 (en) Alpha-amylase variant with altered properties
AU2001263341A1 (en) Snippet selection
AU2001265007A1 (en) Open-back hat
AU2002364573A1 (en) Dynamic cannula
AU2001267851A1 (en) Oxygen-containing ophthalmic composition
AU2003232009A1 (en) Catheter with protective sleeve
AU2001281852A1 (en) Highly concentrated stable meloxicam solutions
AU2001259210A1 (en) Multi-lumen intravenous extension
AU2001259561A1 (en) Tgfbeta-rii promoter polymorphisms
AUPR409401A0 (en) Analgesic compound
AU2001225164A1 (en) Compositions with enhanced oral bioavailability
AU3472600A (en) Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists
AU7978000A (en) Indium-enhanced bipolar transistor
AU2001232295A1 (en) Resin composition for preventing attachment of aquatic organism or physiologicalsubstance
AU2001286141A1 (en) Perfusion cannula
AU5991400A (en) Manometer with direct passage
AU2001295455A1 (en) Indoline derivatives as 5ht2c antagonists
AU2002311389A1 (en) Crosslinkable composition
AU2001261338A1 (en) Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder
AU2001276919A1 (en) Haplotypes of the mmp13 gene
AU1138501A (en) Blended polycarbonate compositions
AU2001249446A1 (en) Diagnostic polymorphisms of tgf-beta-rii promoter
AU2001284680A1 (en) Haplotypes of the alas2 gene